Skip to main content

Intelligent Tutoring System Intervention in Enhancing Genetic Risk Assessment in Underserved Blacks and Latinas at Risk of Hereditary Breast Cancer

Trial Status: Active

This trial studies an intelligent tutoring system intervention in enhancing genetic risk assessment in underserved Blacks and Latinas at risk of hereditary breast cancer. The intelligent tutoring system intervention (BRCA-gist) is a web-based tutoring system that provides education about hereditary breast and ovarian cancer. BRCA-gist may enhance the knowledge and use of genetic cancer risk assessments in at-risk Latina and Black women.

Inclusion Criteria

  • Participants will self-identify as Black and/or Latina
  • Participants will be at high risk of carrying HBOC mutation using personal/family cancer histories based on the National Comprehensive Cancer Network (NCCN) guidelines
  • Providers

Exclusion Criteria

  • Non-English proficiency
  • Not being able to provide informed consent

District of Columbia

Comprehensive Breast Center
Contact: Lucile Lauren Adams-Campbell
MedStar Georgetown University Hospital
Status: ACTIVE
Contact: Alejandra Hurtado de Mendoza
Phone: 202-687-8916
Nueva Vida, Inc.
Contact: Claudia Campos


Virginia Commonwealth University / Massey Cancer Center
Contact: Vanessa L Sheppard


I. Adapt BRCA-gist.

II. Test the feasibility, acceptability, and efficacy of BRCA-gist intervention in a two-arm randomized controlled trial (RCT).


I. Explore differences by ethnicity and health literacy and assess emotional reactions to risk information to inform future affective-tailored interventions.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants use the BRCA-gist web-based tutoring system over 90 minutes.

ARM II: Participants read information about hereditary breast and ovarian cancer (HBOC) and BRCA 1/2 on the National Cancer Institute's (NCI) website over 90 minutes.

After completion of study, participants are followed up at 3 months.

Trial Phase Phase NA

Trial Type Screening

Lead Organization
MedStar Georgetown University Hospital

Principal Investigator
Alejandra Hurtado de Mendoza

  • Primary ID 2017-0524
  • Secondary IDs NCI-2019-01065
  • ID NCT03511690